TIBER CREEK GROUP for ORGANON, LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (PL 118-159)
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| COREY MALMGREN | — |
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| COREY MALMGREN | — |
Budget/Appropriations BUD
Issues related to women's health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| COREY MALMGREN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.